Jump to Content
Jump to Main Navigation
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
Search
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Search
Advanced Search
Help
Search
Table of Contents
Front Matter
Show Items
PART I: Elixir/Solution/Suspension/Syrup
Show Items
PART II: Topical/Ophthalmic Solution
Bacitracin Ophthalmic Solution 9,600 units/mL
Cefazolin Ophthalmic Solution 33 mg/mL
Cidofovir Intravitreous Solution 0.2 mg/mL
Cidofovir Intravitreous Solution 8.1 mg/mL
Fumagillin Ophthalmic Solution 70 mcg/mL
Ganciclovir Intravitreous Solution 20 mg/mL
Gentamicin Ophthalmic Solution 13.6 mg/mL (Fortified)
LET (Lidocaine 4%/Racepinephrine 0.225%/ Tetracaine 0.5%) Topical Solution
Tobramycin Ophthalmic Solution 13.6 mg/mL (Fortified)
Tobramycin Ophthalmic Solution 15 mg/mL
Vancomycin Ophthalmic Solution 31 mg/mL
Voriconazole Ophthalmic Solution 1 mg/mL
Voriconazole Ophthalmic Solution 10 mg/mL
PART III: Commercially Available Products
Show Items
Back Matter
Show Items
Cidofovir Intravitreous Solution 8.1 mg/mL
in
Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients
Editors:
Rita K. Jew
,
Winson Soo-Hoo
,
Sarah C. Erush
, and
Elham Amiri
DOI:
https://doi.org/10.37573/9781585285259.139
Restricted access
Buy Book in ASHP Store
[100.24.122.117]
100.24.122.117
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save